Related Experiment Video

Updated: Apr 23, 2026

Isolating Myofibrils from Skeletal Muscle Biopsies and Determining Contractile Function with a Nano-Newton Resolution Force Transducer
07:55

Isolating Myofibrils from Skeletal Muscle Biopsies and Determining Contractile Function with a Nano-Newton Resolution Force Transducer

Published on: May 7, 2020

6.5K

Biomechanical characterization of myofibrillar myopathies

Lilli Winter1, Wolfgang H Goldmann

  • 1Institute of Neuropathology, University Hospital Erlangen, Erlangen, Germany.

Cell Biology International
|September 30, 2014
PubMed

Insights

Myofibrillar myopathies (MFMs) cause muscle weakness due to mutations in specific genes. Mutant muscle cells are stiffer and more vulnerable to mechanical stress, potentially leading to degeneration.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Genetics

Background:

  • Myofibrillar myopathies (MFMs) are debilitating inherited and sporadic skeletal muscle disorders.
  • Mutations in genes like desmin and plectin are common causes of MFMs.
  • These conditions result in significant physical disability and reduced lifespan.

Purpose of the Study:

  • To investigate the biomechanical properties of muscle cells with mutations linked to MFMs.
  • To understand how genetic mutations affect cellular mechanics and contribute to disease pathogenesis.

Main Methods:

  • Biomechanical analysis of primary human myoblasts.
  • Comparison of cellular stiffness and mechanical stress tolerance between mutant and control cells.
  • Focus on desmin and plectin mutations.

Main Results:

  • Myoblasts with desmin and plectin mutations exhibited increased cellular stiffness.
  • Mutant cells demonstrated reduced tolerance to mechanical stress, indicating higher vulnerability.
  • This increased stiffness may induce higher intracellular stress during physiological deformation.

Conclusions:

  • Cellular stiffness and mechanical vulnerability are key factors in MFM pathogenesis.
  • Biomechanical alterations in muscle cells can trigger the degeneration observed in MFMs.
  • Understanding these mechanisms could inform future therapeutic strategies for myofibrillar myopathies.
Keywords:
intermediate filament proteinsmechano-transductionmyoblastsmyotubes

More Related Videos

Tissue Triage and Freezing for Models of Skeletal Muscle Disease05:58

Tissue Triage and Freezing for Models of Skeletal Muscle Disease

Published on: July 15, 2014

43.2K
Myo-mechanical Analysis of Isolated Skeletal Muscle08:42

Myo-mechanical Analysis of Isolated Skeletal Muscle

Published on: February 22, 2011

29.1K

Related Concept Videos

Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
22
Classification of Skeletal Muscle Fibers01:48

Classification of Skeletal Muscle Fibers

Skeletal muscles continuously produce ATP to provide the energy that enables muscle contractions. Skeletal muscle fibers can be categorized into three types based on differences in their contraction speed and how they produce ATP, as well as physical differences related to these factors. Most human muscles contain all three muscle fiber types, albeit in varying proportions.
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...
48.4K
The Sarcomere01:08

The Sarcomere

A sarcomere is a microscopic segment repeating in a myofibril. The sarcomere fundamentally consists of two main myofilaments: thick filaments called myosin and thin filaments called actin. These filaments interact by sliding past each other in response to stimulus. In addition to myosin and actin, several other proteins, such as tropomyosin, troponin, titin, nebulin, myomesin, α-actinin, and dystrophin, play crucial roles in regulating, structuring, and functioning of the sarcomere.
Each...
18.0K
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
34
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
793
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.2K